US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 14.290
  • +2.730+23.62%
Close Mar 21 16:00 ET
  • 14.540
  • +0.250+1.75%
Post 20:01 ET
124.36MMarket Cap-7.07P/E (TTM)

CervoMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CervoMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.754M--
--2025/Q1-- / 1.962M--
--2024/Q42.162M / 1.747M--
--2024/Q31.940M / 2.800M--
--2024/Q23.289M / 2.200M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.754M--
--2025/Q1-- / 1.962M--
--2024/Q42.162M / 1.747M--
--2024/Q31.940M / 2.800M--
--2024/Q23.289M / 2.200M--

Unlock Free Earnings Estimates

CervoMed Earnings Reports

  • CervoMed | 8-K: CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates

    Mar 18 16:07 ET

  • CervoMed | 10-K: FY2024 Annual Report

    Mar 17 08:20 ET

  • CervoMed | 8-K: CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

    Nov 13, 2024 16:08 ET

  • CervoMed | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 09:33 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +14.85%
    New Fortress Energy
    NFE
    +7.92%
    Cars.com
    CARS
    +2.11%
    Halozyme Therapeutics
    HALO
    +1.31%
    Collegium Pharmaceutical
    COLL
    +0.40%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 19, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-2.82%